OnkoSight^TM Exon Coverage

OnkoSight^TM panels are targeted assays that are meant to be highly actionable and reduce the number of unclear variant results. To that end, coverage of the genes included on OnkoSight^TM panels has been carefully selected, based on the actionable mutations recommended in established national guidelines and published literature.

Next-generation sequencing provides increased gene coverage compared to other testing methods, such as PCR. OnkoSight^TM panels include the latest actionable biomarkers, improving coverage across genes like EGFR, KRAS, and NRAS.

Onkosight CoverageTM
EGFR:	EXON 12	EXON 15	EXON 18	EXON 19	EXON 20	EXON 21
Targeted PCR Coverage